WANT A PROFILE LIKE THIS?

Create my FREE Plan Or learn about other options

Javascript is disabled in your browser. Please enable Javascript to view PeerJ.

PeerJ Editor

1,035 Points

Contributions by role

Contributions by subject area

Huashan Shi

PeerJ Editor

Summary

Professor Shi Huashan is an Associate Professor at Sichuan University. His expertise is in the molecular biology of tumours and tumour transcriptomics. He is currently engaged in clinical and basic translational research, including tumour microenvironment and novel immunotherapeutic modalities, and research on the mechanisms and medical applications related to tumour cell vaccines.

Artificial Intelligence Bioinformatics Cardiology Immunology Microbiology Molecular Biology Oncology Pathology

Editorial Board Member

PeerJ - the Journal of Life & Environmental Sciences

Work details

Associate professor

Sichuan University

West China Hospital

Professor Shi Huashan's expertise is in molecular biology of tumours and tumour transcriptomics. He is currently engaged in clinical and basic translational research, including tumour microenvironment and novel immunotherapeutic modalities, and research on the mechanisms and medical applications related to tumour cell vaccines.

Websites

Google Scholar

PeerJ Contributions

Edited 8

Academic Editor on

February 27, 2025

A nicotinamide metabolism-related gene signature for predicting immunotherapy response and prognosis in lung adenocarcinoma patients

Meng Wang, Wei Li, Fang Zhou, Zheng Wang, Xiaoteng Jia, Xingpeng Han

https://doi.org/10.7717/peerj.18991 PubMed 40034678

September 18, 2024

Value of preoperative prognostic nutritional index combined with NT-proBNP in predicting acute kidney injury of congenital heart disease children

Yan Qiao, Zhenqian Lv, Xiaojun Liu, Baoguo Zhou, Haiping Wang, Gang Wang, Aiping Xie, Chenchen Cheng

https://doi.org/10.7717/peerj.18085 PubMed 39308803

June 21, 2024

Efficacy and safety of Brolucizumab for neovascular age-related macular degeneration: a systematic review and meta-analysis

Ran Dou, Jian Jiang

https://doi.org/10.7717/peerj.17561 PubMed 38915383

March 29, 2024

An androgen receptor-based signature to predict prognosis and identification of ORC1 as a therapeutical target for prostate adenocarcinoma

Linjin Li, Dake Chen, Xiang Chen, Jianlong Zhu, Wenshuo Bao, Chengpeng Li, Feilong Miao, Rui Feng

https://doi.org/10.7717/peerj.16850 PubMed 38562999

February 14, 2024

Galectin-3 promotes fibrosis in ovarian endometriosis

Guimin Yang, Yupeng Deng, Guangming Cao, Chongdong Liu

https://doi.org/10.7717/peerj.16922 PubMed 38371379

October 11, 2023

Beneficial effects of upgrading to His-Purkinje system pacing in patients with pacing-induced cardiomyopathy: a systematic review and meta-analysis

Nian Tang, Xiaoxiao Chen, Hongfei Li, Denghong Zhang

https://doi.org/10.7717/peerj.16268 PubMed 37842060

July 31, 2023

Role of ELK1 in regulating colorectal cancer progression: miR-31-5p/CDIP1 axis in CRC pathogenesis

Guoqiang Yan, Lei Wang

https://doi.org/10.7717/peerj.15602 PubMed 37547727

July 11, 2023

A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma

Jianhua Zhang, Jin Du, Zhihai Jin, Jiang Qian, Jinfa Xu

https://doi.org/10.7717/peerj.15615 PubMed 37456890